brentuximab vedotin News
Most Popular brentuximab vedotin Story
SGN-35 - 10 promising late-stage cancer drugs
After promising results in clinical trials revealed late last year, SGN-35 (brentuximab vedotin) has a shot at being approved later this year for immune system cancers known as Hodgkin's lymphoma and Read more...
Latest Headlines
- April 4, 2011
- September 27, 2010
- December 21, 2009
- August 12, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
